Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

.blurhash-client-img { display: none !important; }

Open Access

|May 2021

Authors

Medical Oncology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Medical Oncology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

General Surgery Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

DOI: https://doi.org/10.2478/fco-2019-0021 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Language: English

Page range: 3 - 11

Submitted on: Jun 14, 2019

Accepted on: Dec 11, 2019

Published on: May 2, 2021

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Related subjects:

© 2021 Heba F. Taha, Ola M. Elfarargy, Reham A. Salem, Doaa Mandour, Amira A. Salem, Mohamed Riad, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.